Renowned Dermatologist’s Love of the Arts is Bringing Joy to Hospital-Bound Children

Renowned Dermatologist’s Love of the Arts is Bringing Joy to Hospital-Bound Children

Dr. Amelia Hausauer M.D. and her father Dr. Amelia Hausauer M.D. Board-Certified Dermatologist at Aesthetx B.A at Stanford University M.D. at University of California, San Francisco Dr. Amelia Hausauer joins the board of Starting Arts, a nonprofit that provides hands-on arts experience in 4 disciplines: dance, music, theatre and visual arts. The arts have a […]

The post Renowned Dermatologist’s Love of the Arts is Bringing Joy to Hospital-Bound Children first appeared on Beauty Ring Magazine.

Continue Reading

BillionToOne Publishes UNITY Fetal RhD and Fetal Antigen NIPT Clinical Validity Demonstrating >99.9% Accuracy

BillionToOne Publishes UNITY Fetal RhD and Fetal Antigen NIPT Clinical Validity Demonstrating >99.9% Accuracy

In a clinical validation study published on Scientific Reports, UNITY RhD NIPT and Fetal antigen NIPT demonstrated 100% sensitivity, 100% specificity, 99.9% precision with 0.1% no-call rate across 3,921 NIPT assays.

The post BillionToOne Publishes UNITY Fetal RhD and Fetal Antigen NIPT Clinical Validity Demonstrating >99.9% Accuracy first appeared on Enrose Magazine.

Continue Reading

Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology

Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology

The ImageneOI rapid AI-based biomarker profiling platform significantly improves lung cancer patient outcomes, as demonstrated by a recently published case report.

Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology
ImageneOI Platform and Case Report

ImageneOI AI-based Molecular Profiling Platform on OCI, and the published case report of impacting patients’ lives.

Imagene, an emerging leader in AI-based precision oncology, is proud to announce the launch of the ImageneOI platform on Oracle Cloud Infrastructure (OCI). The innovative platform, supported by proven clinical benefits, sets a new paradigm in cancer diagnostics by enabling rapid AI-based molecular profiling from biopsy images alone, overcoming key barriers and limitations in current diagnostic processes. ImageneOI already proved its significant impact under research on treatment initiation and averting radiation for two cancer patients, as published in a recent case report in the Journal of Clinical Pathology.

“We’re confident in selecting Oracle as our cloud provider and are pleased to join forces with Oracle in our mission to make advanced technologies drive better patient care,” said Dean Bitan, co-founder and CEO of Imagene. “Oracle is not only delivering consistent, high-performance computing with widespread global reach, but its focus on the healthcare sector has played a crucial role in enabling us to bring this transformative service to the forefront of cancer diagnostics.”

For AI inference computation and to process data at scale, Imagene partnered with Oracle to run its ImageneOI platform on OCI and will take advantage of OCI Supercluster and OCI AI infrastructure technology. OCI’s cost-effective, high-performance computing enables the ImageneOI platform to offer rapid biomarker profiling and to deliver impressive performance of approximately two minutes from uploading a digitized biopsy image to receiving a biomarkers status report. 

“Saving lives is technology’s single most important use,” said Safra Catz, CEO of Oracle. “We are proud that Oracle’s highly performant and secure cloud infrastructure will help Imagene improve access to care, drive informed decisions, lower costs, and ultimately save lives.”

ImageneOI aligns with oncology clinical guidelines that emphasize the importance of obtaining molecular testing for actionable cancer biomarkers before initiating treatment. This breakthrough technology paves the way for improved and personalized cancer care. It facilitates informed decision-making for optimal treatment strategies by reducing turnaround times from weeks to minutes.

The platform transforms cancer diagnosis by addressing a significant gap in the current healthcare landscape. In the United States, approximately 80 percent of cancer patients choose to receive treatment in community settings. In addition, 64 percent of lung cancer patients, which is the deadliest cancer, do not receive the optimal treatment mostly due to biomarker testing-related challenges and limited access to comprehensive Next-Generation Sequencing (NGS). Up to 30 percent of tested patients do not receive guidelines-recommended biomarkers testing results prior to first-line therapy initiation. This accessibility issue and under-tested populations presents a major obstacle to effective cancer treatment.

The pressing need and demand for rapid and accurate cancer diagnosis pose a significant challenge in advancing precision oncology. This challenge is highlighted by the projected rise in cancer incidence, lengthy turnaround times, and issues with tissue inadequacy. The accessibility of the ImageneOI platform on OCI makes it an invaluable rapid molecular profiling resource for research institutions and medical centers globally.

In conjunction with the launch, Imagene is initiating an Early Access Research Program. Interested parties are encouraged to get in touch for more information at [email protected].

About Oracle:

Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.

About Imagene:

Imagene is an emerging leader in AI-based precision oncology. The company leverages AI to profile, within minutes, a broad range of cancer biomarkers from a digitized biopsy image alone, providing physicians with immediate oncology intelligence to ensure optimal treatment for all cancer patients. Visit imagene-ai.com 

Trademarks

Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company–ushering in the new era of cloud computing.

Contact Information:

Avital Rabani

Head of Marketing

[email protected]

Original Source:

Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology

The post Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology first appeared on Enrose Magazine.

Continue Reading

Susanna Falken Jewellery

Susanna Falken Jewellery

Bengt Warborn, Susanna Falken och Michael Falken A New Era of Sustainable and Allergen-Free Jewelry STOCKHOLM, SWEDEN, August 9, 2023/EINPresswire.com/ — Susanna Falken Jewellery: A New Era of Sustainable and Allergen-Free JewelryJewelry enthusiasts and conscious consumers alike have a reason to celebrate as Susanna Falken Jewellery officially launches its e-commerce platform and announces a significant […]

The post Susanna Falken Jewellery first appeared on Beauty Ring Magazine.

Continue Reading

Inland Empire Health Plan launches collaboration with Riverside muralist Juan Navarro

Inland Empire Health Plan launches collaboration with Riverside muralist Juan NavarroRANCHO CUCAMONGA, Calif., Aug. 3, 2023 /PRNewswire/ — Juan Navarro wants to create art for everyone. Inspired by his Mexican-American roots, the Riverside-based muralist leaves his mark on communities and organizations serving diverse populations with each swipe of his paint brush. Continue Reading Inland Empire Health Plan (IEHP) and Riverside-based artist Juan Navarro have partnered […]

Continue Reading

The Holistic Living Journal Secures #26 Spot Among Top 100 Holistic Blogs on the Web

The Holistic Living Journal Secures #26 Spot Among Top 100 Holistic Blogs on the Web

The Holistic Living Journal clinches #26 in Feedspot’s Top 100 Holistic Blogs, celebrating its commitment to premium holistic health & wellness content. Being recognized not just among the top blogs but also achieving the #26 spot amplifies our drive to persistently elevate our offerings.” — Celeste Miranda, Publisher and Co-Founder SAN LUIS OBISPO, CALIFORNIA, UNITED […]

The post The Holistic Living Journal Secures #26 Spot Among Top 100 Holistic Blogs on the Web first appeared on Beauty Ring Magazine.

Continue Reading

Next-Generation Personalized Beauty Market Size, Share And Growth Analysis For 2023-2032

Next-Generation Personalized Beauty Market Size, Share And Growth Analysis For 2023-2032

Next-Generation Personalized Beauty Global Market Report 2023 The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 LONDON, GREATER LONDON, UK, August 9, 2023/EINPresswire.com/ — The Business Research Company’s “Next-Generation Personalized Beauty Global Market Report 2023” is a comprehensive source of […]

The post Next-Generation Personalized Beauty Market Size, Share And Growth Analysis For 2023-2032 first appeared on Beauty Ring Magazine.

Continue Reading

Non-Invasive Aesthetic Treatment Market Size Expected To Reach $99 Billion By 2027

Non-Invasive Aesthetic Treatment Market Size Expected To Reach  Billion By 2027

Non-Invasive Aesthetic Treatment Global Market Report 2023 The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 LONDON, GREATER LONDON, UK, August 9, 2023/EINPresswire.com/ — The Business Research Company’s “Non-Invasive Aesthetic Treatment Global Market Report 2023” is a comprehensive source of […]

The post Non-Invasive Aesthetic Treatment Market Size Expected To Reach $99 Billion By 2027 first appeared on Beauty Ring Magazine.

Continue Reading